| Sep 19, 2023 |
Sep 19, 2023 |
Neumora Therapeutics, Inc.
|
CEO |
Buy |
87.5
|
+15,000
|
3.92%
|
✗
|
$189.4K |
| May 16, 2022 |
May 20, 2022 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
15.0
|
-83,960
|
-45.95%
|
✗
|
$13M |
| Mar 1, 2022 |
May 20, 2022 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
10.0
|
-25,000
|
-20.23%
|
✓
|
$3.7M |
| May 16, 2022 |
May 18, 2022 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
2.5
|
-83,960
|
-46.00%
|
✓
|
$13M |
| Mar 1, 2022 |
Mar 2, 2022 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
10.0
|
-25,000
|
-20.23%
|
✓
|
$3.7M |
| Feb 25, 2022 |
Mar 1, 2022 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
3.8
|
-45,156
|
-26.76%
|
✓
|
$6.7M |
| Feb 28, 2021 |
Mar 2, 2021 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
17.5
|
-22,833
|
-18.54%
|
✗
|
$2.5M |
| Nov 20, 2020 |
Nov 24, 2020 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
10.0
|
-40,000
|
-24.32%
|
✓
|
$4M |
| Feb 28, 2020 |
Mar 3, 2020 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
17.5
|
-26,038
|
-19.03%
|
✗
|
$2.2M |
| Jul 29, 2019 |
Jul 31, 2019 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Buy |
100.0
|
+30,000
|
62.45%
|
✗
|
$2M |
| Feb 28, 2019 |
Mar 4, 2019 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
17.5
|
-22,956
|
-32.44%
|
✗
|
$1.8M |
| Dec 9, 2018 |
Dec 11, 2018 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
17.5
|
-13,446
|
-41.81%
|
✗
|
$1.2M |
| Nov 29, 2018 |
Nov 30, 2018 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
5.0
|
-42,450
|
-56.90%
|
✓
|
$3.8M |
| Feb 28, 2018 |
Mar 2, 2018 |
AbbVie Inc.
|
EVP, Chief Strategy Officer |
Sell |
17.5
|
-17,418
|
-18.95%
|
✗
|
$2.1M |
| Dec 9, 2017 |
Dec 11, 2017 |
AbbVie Inc.
|
Chief Strategy Officer |
Sell |
17.5
|
-14,235
|
-21.37%
|
✗
|
$1.4M |
| Oct 30, 2017 |
Oct 31, 2017 |
AbbVie Inc.
|
Chief Strategy Officer |
Sell |
10.0
|
-18,300
|
-21.56%
|
✓
|
$1.7M |
| Jul 31, 2017 |
Aug 2, 2017 |
AbbVie Inc.
|
Chief Strategy Officer |
Sell |
51.3
|
-300
|
-0.18%
|
✗
|
$21.1K |
| Jul 31, 2017 |
Aug 2, 2017 |
AbbVie Inc.
|
Chief Strategy Officer |
Sell |
17.5
|
-18,000
|
-17.46%
|
✗
|
$1.3M |
| Feb 28, 2017 |
Mar 2, 2017 |
AbbVie Inc.
|
Chief Strategy Officer |
Sell |
17.5
|
-20,673
|
-16.74%
|
✗
|
$1.3M |
| Dec 9, 2016 |
Dec 9, 2016 |
AbbVie Inc.
|
Chief Strategy Officer |
Sell |
20.0
|
-13,871
|
-15.23%
|
✗
|
$844.7K |